Invuity’s patented Intelligent Photonics™ devices provide direct visualization of the surgical cavity enabling enhanced precision, efficiency and safety. Our technology is integrated into sophisticated retractor systems, handheld devices and intracavity drop-in illuminators; each utilizing our proprietary waveguide technology that directs and shapes light into broad, uniform illumination to provide enhanced direct visualization inside dark surgical cavities. In addition, it converts traditional thermally hot, concentrated light output to thermally cool volumetric illumination throughout the entire surgical cavity.
Transforming Minimal access Surgeries Through Advanced Visualization
Invuity is committed to leveraging advanced photonics technology to transform and create a new standard of care for minimal access surgery.
Achieves revenue growth of 50% and gross margin expansion over prior year’s fourth quarter SAN FRANCISCO, Feb. 14, 2017 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today reported financial results for the three months and year ended December 31, 2016. Q4 2016 Highlights Revenue grew 50% to $9.4 million compared to revenue of $6.2 million in the 2015 fourth quarter. Gross margin expansion continued to 74.3% compared to 65.9% in the 2015 fourth quarter. Approximately 745 hospitals purchased Invuity devices in the fourth quarter of 2016, up from 530 hospitals in the fourth quarter of 2015. Approximat...Read More
SAN FRANCISCO, Feb. 06, 2017 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading surgical photonics company, today announced that company management is scheduled to present at the Leerink Partners 6th Annual Global Healthcare Conference on Thursday, February 16, 2017, at 3:00 p.m. ET in New York City. A live, listen-only webcast of the presentation may be accessed by visiting the Events & Presentations section of the Company's website at www.invuity.com under Investors & Media. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the Company's website for 30 days following the presentation. About Invuity® Invu...Read More
SAN FRANCISCO, Feb. 06, 2017 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading surgical photonics company, today announced that it will release its 2016 fourth quarter and full year financial results after the market closes on Tuesday, February 14, 2017. In conjunction with the release, the Company will host a conference call with the investment community at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on Tuesday, February 14, 2017, to discuss the financial results and other business developments. Interested parties may access the live call via telephone by dialing 1-877-556-8638 (U.S.) or 1-615-247-0174 (International), Conference ID: 59656880. To listen to the live call vi...Read More
“The Invuity Eika illuminated minimally invasive thyroid and parathyroid self-retracting technology has revolutionized our field of endocrine surgery. It allows for smaller incisions while improving surgical efficiency and safety. It provides superior visualization of vital structures, and has reduced operating times, improved patient outcomes, and decreased overall costs of the procedure. I would not do a case without this technology.”
Chief of Surgery, Mission Regional and Trauma Med Ctr.
Director, St. Joseph and Hoag Head & Neck Oncology & Endocrine Center
“Invuity’s Intelligent Photonics Technology is a must-have for all my surgical procedures, particularly lumpectomies, and skin and nipple sparing mastectomies. This technology enables me to make a single inframammary incision and clearly visualize deep into the surgical cavity all the way to the axilla. Additionally, it has enabled me to operate proficiently, improving the viability of the breast flap. I have reduced my surgical times while improving patient safety and aesthetic outcomes.”
Director, Comprehensive Breast Care Surgeons
Medical Director, Breast Health Program
Holy Redeemer Health System
“The Saber Waveguide with Yankauer is one of the most significant technological advancements in orthopedic surgery this year. I’m excited to begin using it in my total hip replacement, oncology and orthopedic trauma surgeries.”
UAB Medical Center